Panbela Therapeutics

About:

Panbela Therapeutics develops small molecule pharmaceuticals for the oncology and acute care markets.

Website: https://panbela.com

Twitter/X: sunbiopharma

Top Investors: Florida Institute for the Commercialization of Florida Technology

Description:

Panbela Therapeutics is a next-generation biopharmaceutical company developing disruptive therapeutics for serious unmet medical needs. The company’s initial programs are aimed at diseases of the pancreas, including pancreatic cancer and pancreatitis. Panbela Therapeutics has scientific collaborations with pancreatic disease experts at Honor Health in Scottsdale, Arizona, Cedars Sinai Medical Center in Los Angeles, the University of Minnesota, Mayo Clinic Scottsdale, the Austin Health Cancer Trials Centre, and the Ashford Cancer Centre in Adelaide, Australia. Founded in 2011, the company is based in Minnesota, United States.